Day: 21 September 2021

Biogen’s wet AMD drug receives US FDA nod posing competition to Roche’s Lucentis

Editor

USA – Biogen Inc together with Samsung Bioepis Company Limited have announced that the USFDA has granted their neovascular age-related macular degeneration (wet AMD) drug, Ranibizumab, approval for use against macular edema. This drug will be in competition with Lucentis, Roche’s blockbuster drug which was approved in 2006 and has accumulated sales of over US$1.61 billion in U.S. this past year. FDA’s approval is another win for Biogen, which in the recent months has been hitting headlines due to its controversial yet trendsetting Alzheimer’s drug Aduhelm. Ranibizumab is an anti-vascular…

Read More

Cadila sells two of its brands as Glenmark bags USFDA nod for generic antibiotic cream

Editor

INDIA – Cadila Healthcare has announced that its subsidiary has inked a pact with Integrace Private Limited to sell two brands, Mifegest and Cytolog at an undisclosed amount. Zydus Healthcare Ltd, a wholly-owned subsidiary of the company, has inked the agreement with Integrace, a part of the portfolio companies of private equity firm True North. “The said transaction is expected to be completed within 30 days from the date of execution of agreement, subject to customary approvals,” Cadila Healthcare said in a regulatory filing. Meanwhile, Cadila’s competitors Glenmark Pharmaceuticals has…

Read More

Lincoln Pharma acquires plant for making pneumonia, bronchitis antibiotics

Editor

INDIA – Indian drug maker Lincoln Pharmaceuticals Limited has acquired a facility in Mehsana state in India that makes antibiotics used in the treatment of pneumonia and bronchitis, among other ailments. The acquisition along with capacity expansion and modernization entails an investment of US$4.07 million (Rs 30 crore) which Lincoln Pharma will fund through internal accruals. The plant will manufacture Cephalosporin products which is a bactericidal, broad-spectrum, and β-lactam antibiotic originally derived from fungus Acremonium. To be manufactured in tablet, capsule, dry syrup and injectable forms, Cephalosporin is used to…

Read More

CONSA unveils Sickle Cell screening facility for newborns in Liberia

Editor

LIBERIA – The Ministry of health in Liberia in collaboration with the Consortium on Newborn Screening in Africa (CONSA) have launched a new facility for infant Sickle Cell Disease screening at the country’s leading hospital, John F. Kennedy Medical Center (JFKMC). The Liberian Health Ministry also admonished medical doctors, nurses, as well as health practitioners to buff efforts in providing health and social counselling for patients of sickle cell for societal integration. Sickle cell disease is an inherited red blood cell disorder that can cause debilitating pain and lead to…

Read More

Increase in local vaccine production prompts India to resume exports

Editor

INDIA – Indian government officials have announced that the nation will resume COVID-19 vaccines exports next month, a move likely to help developing nations that have struggled to vaccinate their populations after the Asian nation halted overseas shipments. India’s health minister Mansukh Mandaviya, said that the vaccines production will likely increase in the coming weeks and would help fulfill the nations commitment to COVAX- a United Nations-backed vaccine sharing initiative. He said that India will produce over 300 million vaccine doses in October and hit a target of at least…

Read More